FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

9 letters match. Newest first.

  1. GSC Products, LLC

    FDA told GSC Products its Sinus Plumber headache nasal spray is an unapproved new drug sold online without FDA approval.

    High risk
  2. Aja Health and Wellness Inc.

    FDA warns Aja Health and Wellness that its Aja Migraine Relief nasal spray is an unapproved, misbranded OTC drug.

    Medium
  3. AceCosm

    AceCosm’s website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.

    High risk
  4. White Label Leaf, LLC/Flying Monkey US, LLC

    FDA warned Flying Monkey US that its Delta-8 THC gummies are adulterated food and are being sold as unapproved new drugs.

    High risk
  5. Formulation Technology, Inc.

    FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.

    High risk
  6. Jackson Health & Wellness Clinic

    FDA warned Jackson Health & Wellness Clinic that website claims for Dr. Miller’s teas and supplements make them unapproved and misbranded drugs.

    Low
  7. Fibromyalgia Treatment Group - FTG, LLC

    FDA warned Fibromyalgia Treatment Group that its Fibrolief, Nerve Renew and other supplements are unapproved new drugs sold with disease-treatment claims.

    High risk
  8. NeuroHydrate LLC

    FDA warned NeuroHydrate that its HM-FORMULA supplement is an unapproved new drug because website claims say it prevents migraine.

    Medium
  9. Sage Moon Apothecary LLC

    FDA warned Sage Moon Apothecary that Golden Milk and Elderberry products were unapproved new drugs with disease claims.

    Medium